![Reimar Schlingensiepen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Reimar Schlingensiepen
Chief Executive Officer at AudioCure Pharma GmbH
Network origin in Reimar Schlingensiepen first degree
Entity | Entity type | Industry | |
---|---|---|---|
JADO Technologies GmbH
![]() JADO Technologies GmbH Drugstore ChainsRetail Trade JADO Technologies GmbH develops novel small molecule drugs. It offers drugs based on an unrivalled insight into cell membrane biology and the role of specific cellular domains, including lipid rafts. The firm's technology provides an insight into diverse pathological mechanisms and drives the design of innovative drugs with new modes of action. The company was founded by Teymuras Kurzchalia, Hans-Joachim Knölker, Gary Jennings, Kai Simons and Marino Zerial in 2001 and is headquartered in Dresden, Germany.
6
| Extinct | Drugstore Chains | 6 |
AudioCure Pharma GmbH
![]() AudioCure Pharma GmbH Pharmaceuticals: MajorHealth Technology AudioCure Pharma GmbH provides preclinical research and clinical development of novel pharmacotherapies to treat disorders of the inner ear. It engages in the clinical development of drug candidates in neurodegenerative disease indications. The firm's offer medicine for the treatment of acute and chronic hearing impairments via local, regenerative therapy of the damaged nerve cells in the inner ear. The company was founded by Hans Rommelspacher in 2010 and is headquartered in Berlin, Germany.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Reimar Schlingensiepen via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Helsinki | College/University | Doctorate Degree | |
Bausch & Lomb, Inc.
![]() Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
Mount Sinai Hospital Medical Center
![]() Mount Sinai Hospital Medical Center Hospital/Nursing ManagementHealth Services Mount Sinai Hospital is a 431-bed teaching, research and tertiary-care facility. Mount Sinai is a member of Sinai Health System, along with Schwab Rehabilitation Hospital, Sinai Community Institute, Sinai Medical Group and Sinai Children's Hospital.Mount Sinai provides health services to Chicago's West Side Community, as well as to others in the metropolitan area who require sophisticated medical and surgical care. Mount Sinai's medical offerings include a Level I trauma center; a child-abuse diagnosis, treatment and prevention unit; and a high-risk maternity and infant intensive-care program (Level III perinatal center) | Hospital/Nursing Management | Corporate Officer/Principal | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
UCB Celltech
![]() UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The company is based in Slough, UK and was founded in 2006. | Biotechnology | Director/Board Member | |
UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Cape Town | College/University | Undergraduate Degree | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
The European Molecular Biology Laboratory | College/University | Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Sales & Marketing | |
Hanover College | College/University | Corporate Officer/Principal | |
University of Karlsruhe | College/University | Director/Board Member | |
Dresden University of Technology | College/University | Corporate Officer/Principal | |
Ribonetics GmbH
![]() Ribonetics GmbH BiotechnologyHealth Technology Part of Baxter International, Inc., Ribonetics GmbH is a German company that develops RILON technology, a therapeutic treatment. The company is located in Germany. Ribonetics was acquired by Nexell Therapeutics, Inc. on May 23, 1996 for $1.50 million. | Biotechnology | Corporate Officer/Principal | |
HepaVec AG
![]() HepaVec AG Pharmaceuticals: MajorHealth Technology Part of Evotec SE, HepaVec AG is a German pharmaceutical company that develops pharmaceutical products. The company is based in Berlin, Germany. HepaVec was acquired by DeveloGen AG on May 01, 2000 for $46.57 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The University of York | College/University | Doctorate Degree | |
University of Trieste | College/University | Doctorate Degree | |
National Academy of Sciences
![]() National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
bmp Ventures /Venture Capital/
![]() bmp Ventures /Venture Capital/ Investment ManagersFinance bmp Ventures /Venture Capital/ (bmp Ventures) is the venture capital arm of bmp Ventures AG. It was founded by Oliver Borrmann in 1997. The firm is headquartered in Berlin, Germany, with another German office located in Magdeburg. | Investment Managers | Private Equity Investor |
Statistics
International
United States | 9 |
Germany | 8 |
United Kingdom | 3 |
Belgium | 3 |
Finland | 2 |
Sectoral
Health Technology | 13 |
Consumer Services | 9 |
Commercial Services | 3 |
Health Services | 2 |
Finance | 2 |
Operational
Corporate Officer/Principal | 14 |
Founder | 6 |
Director/Board Member | 4 |
Doctorate Degree | 3 |
Chief Executive Officer | 3 |
Most connected contacts
- Stock Market
- Insiders
- Reimar Schlingensiepen
- Company connections